SCHEMBL8150809

SCHEMBL8150809

CN(C)CCNC(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.63
RAB9A P51151 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
DRD2 P14416 2/20 0.62
DRD4 P21917 2/20 0.62
DRD3 P35462 2/20 0.62
MCHR1 Q99705 1/20 0.61
SETD7 Q8WTS6 1/20 0.60
ALDH1A1 P00352 2/20 0.60
HPGD P15428 1/20 0.58
HIF1A Q16665 1/20 0.56
MAPT P10636 2/20 0.56
THRB P10828 1/20 0.56
TP53 P04637 1/20 0.55
TMEM97 Q5BJF2 1/20 0.55
SIGMAR1 Q99720 1/20 0.55
HDAC4 P56524 1/20 0.54
HDAC1 Q13547 1/20 0.54
HDAC6 Q9UBN7 1/20 0.54
ALOX5 P09917 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5582704 0.92 MCHR1 (0.70) NPC1RAB9ASMN1; SMN2MCHR1MAPT
SCHEMBL2087431 0.90 ALDH1A1 (0.62) NPC1RAB9ASMN1; SMN2SETD7ALDH1A1
Hydrochloric Acid SCHEMBL20547794 0.88 ALDH1A1 (0.60) NPC1RAB9ASMN1; SMN2SETD7ALDH1A1
SCHEMBL8484244 0.88 MCHR1 (0.54) NPC1RAB9ASMN1; SMN2DRD2DRD4
SCHEMBL30046741 0.88 ALDH1A1 (0.73) SMN1; SMN2SETD7ALDH1A1HPGDTHRB
Hydrochloric Acid SCHEMBL8483231 0.87 MCHR1 (0.53) NPC1RAB9ASMN1; SMN2DRD2DRD4
SCHEMBL24061100 0.86 HTT (0.57) SMN1; SMN2DRD2DRD4DRD3MCHR1
SCHEMBL3145464 0.84 SETD7 (0.52) NPC1RAB9ASMN1; SMN2DRD2DRD4
SCHEMBL3141624 0.84 SETD7 (0.58) SMN1; SMN2DRD2DRD4DRD3MCHR1
SCHEMBL21551978 0.84 TP53 (0.62) NPC1RAB9AMCHR1ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042855-A1 BENZAMIDE mGluR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME DEPARTMENT OF VETERANS AFFAIRS 2009-02-12 US disclosed
WO-2008151184-A1 BENZAMIDE MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME VANDERBILT UNIVERSITY (US) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042855-A1 BENZAMIDE mGluR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME GRM5, GRIK5, GRM3 NPC1 2371/4885RAB9A 3119/4885SMN1; SMN2 2385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.